Cargando…

Myeloperoxidase and Advanced Oxidation Protein Products in the Cerebrospinal Fluid in Women and Men with Parkinson’s Disease

Background: Myeloperoxidase (MPO) and advanced oxidation protein products, or AOPP (a type of MPO-derived chlorinated adducts), have been implicated in Parkinson´s disease (PD). Human MPO also show sex-based differences in PD. The objective was to study the relationship of MPO and AOPP in the cerebr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernández-Espejo, Emilio, Rodríguez de Fonseca, Fernando, Gavito, Ana Luisa, Córdoba-Fernández, Antonio, Chacón, José, Martín de Pablos, Ángel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219636/ https://www.ncbi.nlm.nih.gov/pubmed/35739985 http://dx.doi.org/10.3390/antiox11061088

Ejemplares similares

Salivary ATP13A2 is a potential marker of therapy-induced motor complications and is expressed by inclusions in submandibulary glands in Parkinson ´s disease
por: Fernández-Espejo, Emilio, et al.
Publicado: (2022)

Protein Oxidation Biomarkers and Myeloperoxidase Activation in Cerebrospinal Fluid in Childhood Bacterial Meningitis
por: Rugemalira, Emilie, et al.
Publicado: (2019)

Serum from Parkinson’s disease patients presents excess of protein halogenation and nitrosylation, with anomalous nitrosylation of serum α-synuclein as potentially etiological factor
por: Fernandez, Emilio, et al.
Publicado: (2013)

Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson’s disease
por: Pisani, Valerio, et al.
Publicado: (2012)

Metabolomic investigations in cerebrospinal fluid of Parkinson's disease
por: Willkommen, Desiree, et al.
Publicado: (2018)

Alteration in the Cerebrospinal Fluid Lipidome in Parkinson’s Disease: A Post-Mortem Pilot Study
por: Fernández-Irigoyen, Joaquín, et al.
Publicado: (2021)

Native α-Synuclein, 3-Nitrotyrosine Proteins, and Patterns of Nitro-α-Synuclein-Immunoreactive Inclusions in Saliva and Submandibulary Gland in Parkinson’s Disease
por: Fernández-Espejo, Emilio, et al.
Publicado: (2021)

Cerebrospinal Fluid Lysosomal Enzymes and Alpha-Synuclein in Parkinson's Disease
por: Parnetti, Lucilla, et al.
Publicado: (2014)

Ceruloplasmin functional changes in Parkinson’s disease-cerebrospinal fluid
por: Barbariga, Marco, et al.
Publicado: (2015)

Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
por: Hall, Sara, et al.
Publicado: (2016)

Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson’s Disease
por: Zimmermann, Milan, et al.
Publicado: (2022)

Clearing Extracellular Alpha-Synuclein from Cerebrospinal Fluid: A New Therapeutic Strategy in Parkinson’s Disease
por: Menéndez-González, Manuel, et al.
Publicado: (2018)

Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease
por: Schröder, Jens B., et al.
Publicado: (2018)

Cerebrospinal fluid proteomics implicates the granin family in Parkinson’s disease
por: Rotunno, Melissa S., et al.
Publicado: (2020)

Cerebrospinal Fluid Cytokines and Neurodegeneration‐Associated Proteins in Parkinson's Disease
por: Wijeyekoon, Ruwani S., et al.
Publicado: (2020)

Cerebrospinal Fluid Metabolome in Parkinson’s Disease and Multiple System Atrophy
por: Kwon, Do Hyeon, et al.
Publicado: (2022)

Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson’s disease
por: Lobanova, Evgeniia, et al.
Publicado: (2021)

Lipid Metabolism Disorder in Cerebrospinal Fluid Related to Parkinson’s Disease
por: Qiu, Jiewen, et al.
Publicado: (2023)

A New Technique for Collection of Cerebrospinal Fluid in Rat Pups
por: Rodríguez-Fanjul, Javier, et al.
Publicado: (2015)

Embryonic cerebrospinal fluid in brain development: neural progenitor control
por: Gato, Angel, et al.
Publicado: (2014)

The embryonic blood-cerebrospinal fluid barrier function before the formation of the fetal choroid plexus: role in cerebrospinal fluid formation and homeostasis
por: Bueno, David, et al.
Publicado: (2014)

Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach
por: van Dijk, Karin D., et al.
Publicado: (2010)

T-Cell Subsets in the Cerebrospinal Fluid and Peripheral Blood of Patients with Parkinson's Disease
por: Pavón, N., et al.
Publicado: (1992)

Increased Noradrenaline as an Additional Cerebrospinal Fluid Biomarker in PSP-Like Parkinsonism
por: Cerroni, Rocco, et al.
Publicado: (2020)

Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease
por: Irwin, David J., et al.
Publicado: (2020)

Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis
por: Hatcher-Martin, J. M., et al.
Publicado: (2021)

Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach
por: Marques, Tainá M., et al.
Publicado: (2021)

Corrigendum to: Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson’s disease
Publicado: (2021)

Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s disease
por: Karayel, Ozge, et al.
Publicado: (2022)

Myeloperoxidase-Dependent LDL Modifications in Bloodstream Are Mainly Predicted by Angiotensin II, Adiponectin, and Myeloperoxidase Activity: A Cross-Sectional Study in Men
por: Zouaoui Boudjeltia, Karim, et al.
Publicado: (2013)

Cerebrospinal Fluid
por: Bailey, Cleta Sue, et al.
Publicado: (1997)

Cerebrospinal Fluid
por: Vernau, William, et al.
Publicado: (2008)

Embryonic blood-cerebrospinal fluid barrier formation and function
por: Bueno, David, et al.
Publicado: (2014)

A Cross-Sectional Study of Foot Growth and Its Correlation with Anthropometric Parameters in a Representative Cohort of Schoolchildren from Southern Spain
por: González-Elena, María Luisa, et al.
Publicado: (2021)

Cerebrospinal Fluid Biomarkers for Kii Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex
por: Nakayama, Yui, et al.
Publicado: (2013)

Metallomic Biomarkers in Cerebrospinal fluid and Serum in patients with Parkinson’s disease in Indian population
por: Sanyal, Jaya, et al.
Publicado: (2016)

Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders
por: Hall, Sara, et al.
Publicado: (2018)

Cerebrospinal Fluid Galectin-1 Levels Discriminate Patients with Parkinsonism from Controls
por: Marques, Tainá M., et al.
Publicado: (2018)

Correlated levels of cerebrospinal fluid pathogenic proteins in drug-naïve Parkinson’s disease
por: Murakami, Hidetomo, et al.
Publicado: (2019)

Parkinson’s Disease With Depression: The Correlations Between Neuroinflammatory Factors and Neurotransmitters in Cerebrospinal Fluid
por: Lian, Teng-hong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_necihoqniib1v1u26jh2r69dhu